1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow this condition Literature Review of Gastrointestinal Stromal Neoplasms trials Research Report on Gastrointestinal Stromal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline) Velzatinib, Imatinib - Gastrointestinal Stromal Neoplasms | Phase 3 | Recruiting | GlaxoSmithKline | 800 | 2026-07-27 | 2026-10-05 |
Gastrointestinal Stromal Tumors (1)
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1)
GlaxoSmithKline (1)
Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Greece (1) · Italy (1) · Japan (1) · Netherlands (1) · Norway (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
2025 (1)